Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

AKLI

Akili (AKLI)

Akili Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:AKLI
일자시간출처헤드라인심볼기업
2024/05/1505:16Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AKLIAkili Inc
2024/05/1505:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AKLIAkili Inc
2024/05/1505:01Business WireAkili Reports First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:AKLIAkili Inc
2024/05/0706:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AKLIAkili Inc
2024/04/3021:00Business WireAkili Announces Amended Agreement with Shionogi, Shift in Corporate Strategy and Release Date for First Quarter 2024 Financial ResultsNASDAQ:AKLIAkili Inc
2024/03/0706:28Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:AKLIAkili Inc
2024/03/0706:11Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:AKLIAkili Inc
2024/03/0706:07Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:AKLIAkili Inc
2024/03/0106:01Business WireAkili Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:AKLIAkili Inc
2024/02/2716:00Business WirePureTech Founded Entity Akili Announces Positive Results from Shionogi’s Phase 3 Clinical Trial of Localized Version of Akili’s EndeavorRx ® for Pediatric ADHD Patients in JapanNASDAQ:AKLIAkili Inc
2024/02/2623:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AKLIAkili Inc
2024/02/2622:47Business WireAkili Announces Positive Results from Shionogi’s Phase 3 Clinical Trial of Localized Version of Akili’s EndeavorRx® for Pediatric ADHD Patients in JapanNASDAQ:AKLIAkili Inc
2024/02/2407:43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AKLIAkili Inc
2024/02/2407:28Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:AKLIAkili Inc
2024/02/2321:57Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:AKLIAkili Inc
2024/02/2206:11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AKLIAkili Inc
2024/02/2206:05Business WireAkili Announces Release Date for Fourth Quarter and Full Year 2023 Financial Results, Provides Investor Communications and Board and Corporate Governance UpdatesNASDAQ:AKLIAkili Inc
2024/01/0606:17Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AKLIAkili Inc
2023/12/2106:58Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AKLIAkili Inc
2023/12/1822:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AKLIAkili Inc
2023/12/1822:00Business WireEndeavorRxⓇ, World’s First and Only Prescription Video Game Treatment, Secures FDA Label Expansion for Pediatric ADHD Patients Aged 13-17NASDAQ:AKLIAkili Inc
2023/12/0907:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AKLIAkili Inc
2023/11/1006:12Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AKLIAkili Inc
2023/11/1006:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AKLIAkili Inc
2023/11/1006:02Business WireAkili Reports Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:AKLIAkili Inc
2023/11/0707:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AKLIAkili Inc
2023/11/0707:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AKLIAkili Inc
2023/10/2805:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AKLIAkili Inc
2023/10/2001:27Business WireAkili to Host Third Quarter Financial Results Conference Call and Webcast on Thursday, November 9 at 4:30 p.m. ETNASDAQ:AKLIAkili Inc
2023/10/1405:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AKLIAkili Inc
 검색 관련기사 보기:NASDAQ:AKLI